Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Omega Healthcare Investors Inc    OHI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Omega Healthcare Investors Inc : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Omega Healthcare Investors, Inc. of Class Action Lawsuit and Upcoming Deadline - OHI

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/13/2018 | 02:26pm CET

NEW YORK, NY / ACCESSWIRE / January 13, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Omega Healthcare Investors, Inc. ("Omega" or the "Company") (NYSE: OHI) and certain of its officers. The class action, filed in United States District Court, for the Southern District of New York, and docketed under 17-cv-09024, is on behalf of a class consisting of investors who purchased or otherwise acquired Omega securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Omega securities between February 8, 2017, and October 31, 2017, both dates inclusive, you have until January 16, 2018, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and amount of shares purchased.

[Click here to join this class action]

Omega is a self-administered real estate investment trust ("REIT") that invests in income producing healthcare facilities, including long-term care facilities located in the United States and the United Kingdom.

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) financial and operating results of certain of the Company's operators were deteriorating; (ii) as a result, certain of the Company's operators were experiencing worsening liquidity issues that were significantly impacting the operators' ability to make timely rent payments; (iii) as a result, certain of the Company's direct financing leases were impaired and certain receivables were uncollectible; and (iv) as a result of the foregoing, Defendants' statements about Omega's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

On July 26, 2017, after the market closed, the Company issued a press release entitled, "Omega Announces Second Quarter 2017 Financial Results; Increased Dividend Rate for 20th Consecutive Quarter."

On the next day, July 27, 2017, the Company held a conference call to discuss its second quarter results. On this news, the Company's stock price fell $1.35 per share, or 4%, to close at $32.10 per share on July 27, 2017, on unusually heavy trading volume.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP


© Accesswire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on OMEGA HEALTHCARE INVESTORS
04:03p OMEGA HEALTHCARE INVESTORS INC : FINAL DEADLINE ALERT - Bronstein, Gewirtz & Gro..
01/15 OMEGA HEALTHCARE INVESTORS INC : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossm..
01/15 OMEGA HEALTHCARE INVESTORS INC : DEADLINE TOMORROW: Levi & Korsinsky, LLP Remind..
01/14 OMEGA HEALTHCARE INVESTORS INC : The Klein Law Firm Reminds Investors of a Class..
01/13 OMEGA HEALTHCARE INVESTORS INC : Pomerantz Law Firm Reminds Shareholders with L..
01/13 GLANCY PRONGAY & MURRAY LLP : Reminds Investors of the January 16, 2018 Deadline..
01/12 OMEGA HEALTHCARE INVESTORS : Rosen Law Firm Reminds Omega Healthcare, Investors ..
01/11 OMEGA HEALTHCARE INVESTORS INC : Levi & Korsinsky, LLP Reminds Omega Healthcare,..
01/11 OMEGA HEALTHCARE INVESTORS INC : DEADLINE ALERT - Bronstein, Gewirtz & Grossman,..
01/11 OMEGA HEALTHCARE INVESTORS INC : Pomerantz Law Firm Reminds Shareholders with Lo..
More news
News from SeekingAlpha
01/15 My Dividend Growth Portfolio - Q4 2017 Summary
01/15 ROAD TO FINANCIAL INDEPENDENCE : My December 88-Stock Portfolio Review
01/13 THE PASSIVE DGI CORE PORTFOLIO : 2017 End-Of-Year Review
01/12 Top Dividend Achievers Are Omega Health By Yield And HCP By Net Gains In Janu..
01/12 The Senior Housing Industry May Be At Risk But Deathcare Isn't
Financials ($)
Sales 2017 910 M
EBIT 2017 433 M
Net income 2017 127 M
Debt 2017 4 607 M
Yield 2017 9,76%
P/E ratio 2017 41,33
P/E ratio 2018 14,42
EV / Sales 2017 10,7x
EV / Sales 2018 10,5x
Capitalization 5 152 M
Chart OMEGA HEALTHCARE INVESTORS
Duration : Period :
Omega Healthcare Investors Technical Analysis Chart | OHI | US6819361006 | 4-Traders
Technical analysis trends OMEGA HEALTHCARE INVESTORS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 29,3 $
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
Taylor C. Pickett Chief Executive Officer & Director
Craig R. Callen Chairman
Daniel J. Booth Chief Operating Officer & Secretary
Robert O. Stephenson Chief Financial Officer & Treasurer
Bernard J. Korman Director
Sector and Competitors
1st jan.Capitalization (M$)
OMEGA HEALTHCARE INVESTORS INC-5.16%5 152
WELLTOWER INC-7.23%21 823
VENTAS-8.63%19 528
HCP-9.36%11 090
HEALTHCARE TRUST OF AMERICA INC-9.15%5 591
MEDICAL PROPERTIES TRUST, INC.-7.40%4 647